{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:38:30Z","timestamp":1783485510436,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007628.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:00:00Z","timestamp":1464220800000}}],"reference-count":176,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007628.pub4","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T08:04:46Z","timestamp":1464249886000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Interventions for female pattern hair loss"],"prefix":"10.1002","volume":"2016","author":[{"given":"Esther J","family":"van Zuuren","sequence":"first","affiliation":[{"name":"Leiden University Medical Center; Department of Dermatology; PO Box 9600 B1-Q Leiden Netherlands 2300 RC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbys","family":"Fedorowicz","sequence":"additional","affiliation":[{"name":"Cochrane; Bahrain Branch; Box 25438 Awali Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schoones","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Walaeus Library; PO Box 9600 Leiden Netherlands 2300 RC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1610-0387.2007.06295.x","article-title":"Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women","volume":"5","author":"Blume-Peytavi","year":"2007","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jaad.2010.09.724","article-title":"A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women","volume":"65","author":"Blume-Peytavi","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02850093","article-title":"Essential oils and low-intensity electromagnetic pulses in the treatment of androgen-dependent alopecia","volume":"20","author":"Ginouves","year":"2003","journal-title":"Advances in Therapy"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(02)04551-X","article-title":"Treatment of hyperandrogenic alopecia in women","volume":"79","author":"Carmina","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archderm.1994.01690030035005","article-title":"Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution","volume":"130","author":"DeVillez","year":"1994","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1473-2165.2005.00201.x","article-title":"A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia","volume":"4","author":"Draelos","year":"2005","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2133.2004.05685.x","article-title":"Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial","volume":"150","author":"Fischer","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0008|cit8","first-page":"109","article-title":"Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies","volume":"158","author":"Gassmueller","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"7-8","key":"10.1002\/14651858.CD007628.pub4-BIB0009|cit9","first-page":"419","article-title":"Use of the phototrichogram to assess the stimulation of hair growth - An in vitro study of women with androgenetic alopecia","volume":"75","author":"Gehring","year":"2000","journal-title":"H+G Zeitschrift fur Hautkrankheiten"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000076497","article-title":"Topical estrogen therapy for androgenetic alopecia in menopausal females","volume":"208","author":"Georgala","year":"2004","journal-title":"Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0011|cit11","first-page":"21","article-title":"Usefulness and safety of 0.025 percent 17-alpha-estradiol versus 2 percent minoxidil in the treatment of androgenetic alopecia","volume":"25","author":"Guerrero","year":"2009","journal-title":"Revista Chilena de Dermatologia"},{"issue":"12","key":"10.1002\/14651858.CD007628.pub4-BIB0012|cit12","first-page":"1233","article-title":"The efficacy and safety of a combination cytopurine\/pentadecanoic glyceride topical solution on androgenetic alopecia: A randomized double-blind placebo-controlled clinical trial","volume":"45","author":"Hong","year":"2007","journal-title":"Korean Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD007628.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-4362.1993.tb02755.x","article-title":"Use of topical minoxidil therapy for androgenetic alopecia in women","volume":"32","author":"Jacobs","year":"1993","journal-title":"International Journal of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007628.pub4-BIB0014|cit14","first-page":"S100","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss","volume":"134","author":"Jimenez","year":"2014","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study","volume":"15","author":"Jimenez","year":"2014","journal-title":"American Journal of Clinical Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007628.pub4-BIB0016|cit16","first-page":"S100","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss","volume":"134","author":"Jimenez","year":"2014","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study","volume":"15","author":"Jimenez","year":"2014","journal-title":"American Journal of Clinical Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0018|cit18","first-page":"584","article-title":"Epigenetic markers predict treatment response to finasteride in female androgenetic alopecia: Poster session","volume":"19","author":"Goren","year":"2010","journal-title":"Experimental Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1529-8019.2011.01407.x","article-title":"Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics","volume":"24","author":"Keene","year":"2011","journal-title":"Dermatologic Therapy"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5142\/JGR.2009.33.3.223","article-title":"Study of the efficacy of Korean red ginseng in the treatment of androgenic alopecia","volume":"33","author":"Kim","year":"2009","journal-title":"Journal of Ginseng Research"},{"issue":"8","key":"10.1002\/14651858.CD007628.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/dsu.12200","article-title":"Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial","volume":"39","author":"Kim","year":"2013","journal-title":"Dermatologic Surgery"},{"issue":"8","key":"10.1002\/14651858.CD007628.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/lsm.22277","article-title":"The growth of human scalp hair in females using visible red light laser and LED sources","volume":"46","author":"Lanzafame","year":"2014","journal-title":"Lasers in Surgery and Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/jocd.12127","article-title":"Effect of a nutritional supplement on hair loss in women","volume":"14","author":"Floc'h","year":"2015","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/09546639709160517","article-title":"Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course","volume":"8","author":"Mazzarella","year":"1997","journal-title":"Journal of Dermatological Treatment"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0026|cit26","first-page":"341","article-title":"Androgenetic alopecia in postmenopausal women","volume":"19","author":"Minozzi","year":"1997","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0027|cit27","first-page":"57","article-title":"Effect of gelatin-cystine and serenoa repens extract on free radicals level and hair growth","volume":"16","author":"Morganti","year":"1998","journal-title":"Journal of Applied Cosmetology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD007628.pub4-BIB0028|cit28","first-page":"AB112","article-title":"Effectiveness of once daily 5% minoxidil topical foam in the treatment of women with thinning hair due to female pattern hair loss (FPHL)","volume":"72","author":"Doshi","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0029|cit29","unstructured":"NCT01145625 A Phase 3 multi-center parallel design clinical trial to compare the efficacy and safety of 5% Minoxidil Foam vs. 2% Minoxidil Solution in females for the treatment of female pattern hair loss - androgenetic alopecia (MINALO3004, NCT01145625) clinicaltrials.gov\/ct2\/show\/NCT01145625"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0030|cit30","unstructured":"NCT01189279 Safety and pharmacokinetics study of new formulation of Bimatoprost in patients with alopecia clinicaltrials.gov\/ct2\/show\/NCT01189279"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0031|cit31","unstructured":"NCT01226459 A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam vs. Vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia) clinicaltrials.gov\/ct2\/show\/NCT01226459"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0032|cit32","unstructured":"NCT01325350 Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss clinicaltrials.gov\/ct2\/show\/NCT01325350"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0033|cit33","unstructured":"NCT01655108 Efficacy and Safety of Mesotherapy With Minoxidil 0.5%\/2ml for Androgenetic Alopecia in Female Patients clinicaltrials.gov\/ct2\/show\/NCT01655108"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0034|cit34","unstructured":"NCT01900041 A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss clinicaltrials.gov\/ct2\/show\/NCT01900041"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0035|cit35","unstructured":"NCT01967277 A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy clinicaltrials.gov\/ct2\/show\/NCT01967277"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0036|cit36","first-page":"243","article-title":"Topical minoxidil in the treatment of androgenetic alopecia in women","volume":"48","author":"Olsen","year":"1991","journal-title":"Cutis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007628.pub4-BIB0037|cit37","first-page":"S151","article-title":"Efficacy of adenosine on female pattern hair loss and male androgenetic alopecia","volume":"128","author":"Oura","year":"2008","journal-title":"Journal of Investigative Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD007628.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1346-8138.2008.00564.x","article-title":"Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial","volume":"35","author":"Oura","year":"2008","journal-title":"Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0039|cit39","first-page":"276","article-title":"Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia","volume":"10","author":"Pazoki-Toroudi","year":"2012","journal-title":"Skinmed"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0040|cit40","first-page":"227","article-title":"Effects of application of a pulsed electrostatic field in male and female androgenic alopecia","volume":"47","author":"Policarpi","year":"1993","journal-title":"Annali Italiani di Dermatologia Clinica e Sperimentale"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12514348","article-title":"Quantitative estimation of hair growth. I. androgenetic alopecia in women: effect of minoxidil","volume":"95","author":"Price","year":"1990","journal-title":"Journal of Investigative Dermatology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD007628.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD007628.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0190-9622(87)70087-5","article-title":"Safety and efficacy of topical minoxidil in the management of androgenetic alopecia","volume":"16","author":"Rietschel","year":"1987","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD007628.pub4-BIB0044|cit44","first-page":"583","article-title":"A randomized controlled clinical study on 2% and 5% topical minoxidil solution in the treatment of female pattern hair loss [Chinese]","volume":"43","author":"Sheng","year":"2014","journal-title":"Journal of Clinical Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0045|cit45","first-page":"119","article-title":"The efficacy and safety of AP-FHG0604T on female pattern hair loss: A randomized double-blind placebo-controlled clinical trial","volume":"45","author":"Shin","year":"2007","journal-title":"Korean Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/147323000102900101","article-title":"Efficacy and tolerability of Hairgain\u00ae in individuals with hair loss: a placebo-controlled, double-blind study","volume":"29","author":"Thom","year":"2001","journal-title":"Journal of International Medical Research"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/147323000603400508","article-title":"Nourkrin: objective and subjective effects and tolerability in persons with hair loss","volume":"34","author":"Thom","year":"2006","journal-title":"Journal of International Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0048|cit48","first-page":"37","article-title":"A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women","volume":"17","author":"Tsuboi","year":"2007","journal-title":"European Journal of Dermatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007628.pub4-BIB0049|cit49","first-page":"S238","article-title":"Comparision of low dose finasteride, flutamide and spirolactone in female androgenetic alopecia","volume":"12","author":"Uk\u015fal","year":"1999","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD007628.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-4362.1992.tb04251.x","article-title":"Treatment of female androgenetic alopecia with minoxidil 2%","volume":"31","author":"Whiting","year":"1992","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.jidsp.5640230","article-title":"Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: Results of finasteride 1 mg treatment of men and postmenopausal women","volume":"4","author":"Whiting","year":"1999","journal-title":"Journal of Investigative Dermatology. Symposium Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD007628.pub4-BIB0053|cit53","first-page":"1094","article-title":"Finasteride treatment of female patterned hair loss in postmenopausal women","volume":"44","author":"Ahn","year":"2006","journal-title":"Korean Journal of Dermatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD007628.pub4-BIB0054|cit54","first-page":"880-3, 890-3","article-title":"Topical tretinoin for hair growth promotion","volume":"15","author":"Bazzano","year":"1986","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0055|cit55","first-page":"47","article-title":"The role of microinflammation and apoptosis in androgenic alopecia: New therapeutical strategies","volume":"5","author":"Bezzola","year":"2009","journal-title":"Journal of Plastic Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0056|cit56","first-page":"263","article-title":"2% Minoxidil topical solution in the treatment of alopecia androgenetica. A controlled clinical study","volume":"126","author":"Califano","year":"1991","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD007628.pub4-BIB0057|cit57","first-page":"AB108","article-title":"Single and repeated dose of finasteride topical solution in subjects with androgenetic alopecia: A pharmacokinetic and pharmacodynamic study","volume":"68","author":"Caserini","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0058|cit58","first-page":"1397","article-title":"Pharmacodynamic of P-3074 (finasteride 0.25% topical solution) in subjects with androgenetic alopecia","volume":"133","author":"Caserini","year":"2013","journal-title":"Journal of Investigative Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007628.pub4-BIB0059|cit59","first-page":"S110","article-title":"Pharmacokinetics and pharmacodynamics of finasteride topical solution after single and repeated dose in subjects with androgenetic alopecia","volume":"132","author":"Caserini","year":"2012","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0060|cit60","first-page":"199","article-title":"Clinical investigation of the effects of topical lotion and shampoo containing synthetic thymus peptides on androgenetic alopecia and chronic telogen effluvium in women","volume":"4","author":"Donne Dermatologhe","year":"2008","journal-title":"Journal of Plastic Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0974-7753.114700","article-title":"A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study","volume":"5","author":"Dhurat","year":"2013","journal-title":"International Journal of Trichology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007628.pub4-BIB0062|cit62","first-page":"74","article-title":"Comparison between an herbal drug and 2% minoxidil solution in the treatment of the androgenetic alopecia [Abstract P03.30]. The 14th Congress of the European Academy of Dermatology and Venereology; 2005 Oct 12-15; London","volume":"19","author":"Enshaieh","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0063|cit63","first-page":"39","article-title":"Mucopolysaccharides and depolymerized nucleic acids in the treatment of androgenic alopecia","volume":"6","author":"Farella","year":"1991","journal-title":"Dermatologia Oggi"},{"issue":"11","key":"10.1002\/14651858.CD007628.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0030-1256701","article-title":"Topical melatonin for treatment of androgenetic alopecia","volume":"37","author":"Fischer","year":"2011","journal-title":"Aktuelle Dermatologie"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0974-7753.111199","article-title":"Topical melatonin for treatment of androgenetic alopecia","volume":"4","author":"Fischer","year":"2012","journal-title":"International Journal of Trichology"},{"issue":"106","key":"10.1002\/14651858.CD007628.pub4-BIB0066|cit66","first-page":"29","article-title":"Comparing the effectiveness of local solution of minoxidil and caffeine 2.5% with local solution of minoxidil 2.5% in treatment of androgenetic alopecia","volume":"23","author":"Golpour","year":"2013","journal-title":"Journal of Mazandaran University of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0067|cit67","first-page":"43","article-title":"Effectiveness of a dietary supplement with serenoa serrulata and tocotrienol-tocopherol against female androgenetic alopecia and telogen effluvium. Report of a pilot study","volume":"96","author":"G\u00f3mez Grau","year":"2015","journal-title":"Revista Argentina de Dermatolog\u00eda"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0068|cit68","first-page":"68","article-title":"Treatment of androgenetic alopecia with HairPrime - a 7.5% herbal preparation","volume":"160","author":"Greenberg","year":"1996","journal-title":"Townsend Letter"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jdermsci.2006.08.011","article-title":"Reversal of androgenetic alopecia by topical ketoconzole: Relevance of anti-androgenic activity","volume":"45","author":"Inui","year":"2007","journal-title":"Journal of Dermatological Science"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09513590701214463","article-title":"Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone","volume":"23","author":"Kohler","year":"2007","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1346-8138.2012.01680.x","article-title":"Effects of topical application of growth factors followed by microneedle therapy in women with female pattern hair loss: A pilot study","volume":"40","author":"Lee","year":"2013","journal-title":"Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/wrr.12250","article-title":"Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss","volume":"23","author":"Lee","year":"2015","journal-title":"Wound Repair & Regeneration"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0073|cit73","first-page":"223","article-title":"Randomized double-blind placebo-controlled evaluation of topical minoxidil in the treatment of female androgonetic alopecia","volume":"29","author":"Li","year":"1996","journal-title":"Chinese Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1468-3083.2012.04535.x","article-title":"Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: Photographic, morphometric and ultrustructural evaluation","volume":"27","author":"Moftah","year":"2013","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0075|cit75","first-page":"119","article-title":"Treatment of female androgenetic alopecia with finasteride","volume":"12","author":"Navadeh","year":"2002","journal-title":"NederlandsTijdschrift voor Dermatologie en Venereologie"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000250344","article-title":"Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study","volume":"161","author":"Orfanos","year":"1980","journal-title":"Dermatologica"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0077|cit77","first-page":"15","article-title":"Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial","volume":"13","author":"Panahi","year":"2015","journal-title":"Skinmed"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0078|cit78","first-page":"395","article-title":"The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females","volume":"69","author":"Peereboom-Wynia","year":"1989","journal-title":"Acta Dermato-Venereologica"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/09546639609086877","article-title":"Improvement in the inflammatory aspect of androgenetic alopecia. A pilot study with an antimicrobial lotion","volume":"7","author":"Pi\u00e9rard","year":"1996","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000017954","article-title":"Ketoconazole shampoo: effect of long-term use in androgenic alopecia","volume":"196","author":"Pi\u00e9rard-Franchimont","year":"1998","journal-title":"Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/107555302317371433","article-title":"A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia","volume":"8","author":"Prager","year":"2002","journal-title":"Journal of Alternative and Complementary Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0082|cit82","first-page":"271","article-title":"Evaluation of the efficacy of an extract of Cichorium intybus against hair loss","volume":"63","author":"Rinaldi","year":"2006","journal-title":"Revista Brasileira De Medicina"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD007628.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0190-9622(87)70091-7","article-title":"Androgenetic alopecia: treatment results with topical minoxidil","volume":"16","author":"Roberts","year":"1987","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/153082003769591209","article-title":"Hair regrowth and increased hair tensile strength using the HairMax LaserComb for Low-Level Laser Therapy","volume":"5","author":"Satino","year":"2003","journal-title":"International Journal of Cosmetic Surgery and Aesthetic Dermatology"},{"issue":"Suppl 1 Pt 1","key":"10.1002\/14651858.CD007628.pub4-BIB0085|cit85","first-page":"1S324","article-title":"Treatment of androgenetic alopecia in women with oral antiandrogen therapy","volume":"129","author":"Sinclair","year":"2002","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0087|cit87","first-page":"57","article-title":"Efficacy of a cosmetic caffeine shampoo in androgenetic alopecia management. II Note","volume":"31","author":"Sisto","year":"2013","journal-title":"Journal of Applied Cosmetology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0088|cit88","first-page":"201","article-title":"Effectiveness of spironolactone in reducing hair loss in women with androgenetic alopecia","volume":"61","author":"Slaught","year":"2013","journal-title":"Journal of Investigative Medicine"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD007628.pub4-BIB0089|cit89","first-page":"AB90","article-title":"Enabling finasteride 1 mg users to further improve hair pattern: A randomized, double-blind, placebo-controlled trial of a novel product","volume":"70","author":"Takeda","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0090|cit90","first-page":"3","article-title":"A double blind randomized placebo controlled clinical trial of finasteride in the treatment of androgenetic alopecia","volume":"18","author":"Yang","year":"2002","journal-title":"Chinese Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0091|cit91","unstructured":"NCT01292746 Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human Scalp clinicaltrials.gov\/ct2\/show\/NCT01292746"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0092|cit92","unstructured":"NCT01451021 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss clinicaltrials.gov\/ct2\/show\/NCT01451021"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0093|cit93","unstructured":"NCT01451047 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) clinicaltrials.gov\/ct2\/show\/NCT01451047"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0094|cit94","unstructured":"NCT01451073 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) clinicaltrials.gov\/ct2\/show\/NCT01451073"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0095|cit95","unstructured":"NCT01451099 A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss clinicaltrials.gov\/ct2\/show\/NCT01451099"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0096|cit96","unstructured":"NCT01451112 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) clinicaltrials.gov\/ct2\/show\/NCT01451112"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0097|cit97","unstructured":"NCT01451125 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) clinicaltrials.gov\/ct2\/show\/NCT01451125"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0098|cit98","unstructured":"NCT01451138 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) clinicaltrials.gov\/ct2\/show\/NCT01451138"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0099|cit99","unstructured":"NCT01451151 A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) clinicaltrials.gov\/ct2\/show\/NCT01451151"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0100|cit100","unstructured":"NCT01451177 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) clinicaltrials.gov\/ct2\/show\/NCT01451177"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0101|cit101","unstructured":"NCT01451190 A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) clinicaltrials.gov\/ct2\/show\/NCT01451190"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0102|cit102","unstructured":"ACTRN12607000027415 Double blind placebo controlled trial into the treatment of female pattern hair loss with spironolactone and minoxidil www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=81787"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0103|cit103","unstructured":"EUCTR2013-002740-85-ES A Pilot Randomized, Double-blind, Placebo-controlled Clinical Trial to Obtain Preliminary Data on Efficacy and Safety in the Application of PRGF-Endoret by Mesotherapy, in the Treatment of Male and Female Androgenetic Alopecia of Over 6 Months Duration www.clinicaltrialsregister.eu\/ctr-search\/search?query=EUCTR2013-002740-85-ES"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0104|cit104","unstructured":"NCT00175617 Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss clinicaltrials.gov\/ct2\/show\/NCT00175617"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0105|cit105","unstructured":"NCT00197379 The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia clinicaltrials.gov\/ct2\/show\/NCT00197379"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0106|cit106","unstructured":"NCT00418249 Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women clinicaltrials.gov\/ct2\/show\/NCT00418249"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0107|cit107","unstructured":"NCT01286649 Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia clinicaltrials.gov\/ct2\/show\/NCT01286649"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0108|cit108","unstructured":"NCT01662089 The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement clinicaltrials.gov\/ct2\/show\/NCT01662089"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0109|cit109","unstructured":"NCT01686295 24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness clinicaltrials.gov\/ct2\/show\/NCT01686295"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0110|cit110","unstructured":"NCT01885676 Plasma Rich in Growth Factors (PRGF-Endoret) in the Treatment of Androgenetic Alopecia clinicaltrials.gov\/ct2\/show\/NCT01885676"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0111|cit111","unstructured":"NCT02074943 Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia clinicaltrials.gov\/ct2\/show\/NCT02074943"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0112|cit112","unstructured":"NCT02483195 The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal FemaleAndrogenetic Alopecia clinicaltrials.gov\/ct2\/show\/NCT02483195"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0113|cit113","unstructured":"NCT02486848 Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil clinicaltrials.gov\/ct2\/show\/NCT02486848"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007628.pub4-BIB0114|cit114","first-page":"8","article-title":"The role of the androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation pattern in postmenopausal female pattern hair loss","volume":"159","author":"Ali","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.det.2012.08.005","article-title":"Hair: What is new in diagnosis and management? Female pattern hair loss update: Diagnosis and treatment","volume":"31","author":"Atanaskova Mesinkovska","year":"2013","journal-title":"Dermatologic Clinics"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/lsm.22170","article-title":"Low-level laser (light) therapy (LLLT) for treatment of hair loss","volume":"46","author":"Avci","year":"2014","journal-title":"Lasers in Surgery and Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/09546639809160551","article-title":"A hair growth questionnaire for use in the evaluation of therapeutic effects in men","volume":"9","author":"Barber","year":"1998","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0118|cit118","first-page":"5","article-title":"Androgenetic alopecia and current methods of treatment","volume":"14","author":"Bienov\u00e1","year":"2005","journal-title":"Acta Dermatovenerologica Alpina, Pannonica, et Adriatica"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.0007-0963.2003.05809.x","article-title":"Women who present with female pattern hair loss tend to underestimate the severity of their hair loss","volume":"150","author":"Biondo","year":"2004","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/1874372201004010090","article-title":"Quality of life in Australian women with female pattern hair loss","volume":"4","author":"Biondo","year":"2010","journal-title":"The Open Dermatology Journal"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2230.2002.01085.x","article-title":"Female pattern hair loss","volume":"27","author":"Birch","year":"2002","journal-title":"Clinical and Experimental Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","article-title":"S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents","volume":"164","author":"Blume-Peytavi","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD007628.pub4-BIB0123|cit123","first-page":"S1","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men","volume":"9","author":"Blumeyer","year":"2011","journal-title":"Journal of the German Society of Dermatology"},{"issue":"7572","key":"10.1002\/14651858.CD007628.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bmj.38987.492014.94","article-title":"How to formulate research questions","volume":"333","author":"Brown","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sder.2009.01.001","article-title":"Hair loss in women","volume":"28","author":"Camacho-Mart\u00ednez","year":"2009","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0738-081X(00)00127-9","article-title":"The psychology of hair loss and its implications for patient care","volume":"19","author":"Cash","year":"2001","journal-title":"Clinics in Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0127|cit127","first-page":"189","article-title":"Female pattern hair loss: current treatment concepts","volume":"2","author":"Dinh","year":"2007","journal-title":"Clinical Interventions in Aging"},{"issue":"8","key":"10.1002\/14651858.CD007628.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2230.2000.00726.x","article-title":"Development of a health-related quality of life questionnaire for women with androgenetic alopecia","volume":"25","author":"Dolte","year":"2000","journal-title":"Clinical and Experimental Dermatology"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD007628.pub4-BIB0129|cit129","first-page":"465","article-title":"Guidelines of care for androgenetic alopecia. American Academy of Dermatology","volume":"35","author":"Drake","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7109","key":"10.1002\/14651858.CD007628.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-4632.2009.03991.x","article-title":"Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia","volume":"48","author":"El-Samahy","year":"2009","journal-title":"International Journal of Dermatology"},{"issue":"22","key":"10.1002\/14651858.CD007628.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402005112","article-title":"Androgenic alopecia: pathogenesis and potential for therapy","volume":"4","author":"Ellis","year":"2002","journal-title":"Expert Reviews in Molecular Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1087-0024.2005.10102.x","article-title":"Prevalence of male and female pattern hair loss in Maryborough","volume":"10","author":"Gan","year":"2005","journal-title":"Journal of Investigative Dermatology. Symposium Proceedings"},{"issue":"7650","key":"10.1002\/14651858.CD007628.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE; an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0022-202X.2004.23237.x","article-title":"Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia","volume":"123","author":"Hadshiew","year":"2004","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0136|cit136","first-page":"218","article-title":"Treatment of female pattern hair loss","volume":"10","author":"Hassani","year":"2012","journal-title":"Skinmed"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0137|cit137","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0138|cit138","first-page":"319","article-title":"Current understanding of androgenetic alopecia. Part I: etiopathogenesis","volume":"10","author":"Hoffmann","year":"2000","journal-title":"European Journal of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD007628.pub4-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00105-002-0421-1","article-title":"TrichoScan. A new instrument for digital hair analysis","volume":"53","author":"Hoffmann","year":"2002","journal-title":"Hautarzt"},{"issue":"8","key":"10.1002\/14651858.CD007628.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/1346-8138.12194","article-title":"Effect of hairpieces on perceived quality of life in female pattern hair loss patients: questionnaire based study","volume":"40","author":"Inui","year":"2013","journal-title":"Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1523-1747.2003.12540.x","article-title":"Decreased serum ferritin is associated with alopecia in women","volume":"121","author":"Kantor","year":"2003","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0028-1102905","article-title":"Understanding and management of female pattern alopecia","volume":"24","author":"Leavitt","year":"2008","journal-title":"Facial Plastic Surgery"},{"issue":"8","key":"10.1002\/14651858.CD007628.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/jdv.12034","article-title":"Guidelines for management of androgenetic alopecia based on BASP classification--the Asian Consensus Committee guideline","volume":"27","author":"Lee","year":"2013","journal-title":"Journal of the European Academy of Dermatology & Venereology : JEADV"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0144|cit144","first-page":"541","article-title":"Female pattern alopecia: current perspectives","volume":"5","author":"Levy","year":"2013","journal-title":"International Journal of Women's Health"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0146|cit146","volume-title":"Concise Colour Medical Dictionary. 2nd edition","author":"Martin","year":"1998"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1365-2133.2000.03521.x","article-title":"Thyroid hormone and hair growth","volume":"142","author":"Messenger","year":"2000","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2006.07409.x","article-title":"Follicular miniaturization in female pattern hair loss: clinicopathological correlations","volume":"155","author":"Messenger","year":"2006","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"pii: S1678-7757","DOI":"10.1590\/S1678-77572011000100001","article-title":"Grading the quality of evidence and strength of recommendations: the GRADE approach to improving dental clinical guidelines","volume":"19","author":"Nasser","year":"2011","journal-title":"Journal of Applied Oral Science"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD007628.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2001.117426","article-title":"Female pattern hair loss","volume":"45","author":"Olsen","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Evaluation and treatment of male and female pattern hair loss","volume":"52","author":"Olsen","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-540-46911-7_10","article-title":"Female pattern hair loss","volume-title":"Hair Growth and Disorders","author":"Olsen","year":"2008"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2009.12.006","article-title":"Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups","volume":"63","author":"Olsen","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007628.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1523-1747.2003.12168.x","article-title":"Androgenetic alopecia in women","volume":"8","author":"Price","year":"2003","journal-title":"Journal of Investigative Dermatology. Symposium Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.jaad.2010.11.042","article-title":"Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia","volume":"66","author":"Reid","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0156|cit156","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4238\/2013.February.28.19","article-title":"Increased androgen receptor messenger RNA in frontal-parietal hair follicles of women with androgenetic alopecia","volume":"12","author":"Richeti","year":"2013","journal-title":"Genetics and Molecular Research"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2008.07.001","article-title":"Medical treatments for male and female pattern hair loss","volume":"59","author":"Rogers","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1096\/fj.07-099424","article-title":"Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil","volume":"22","author":"Shorter","year":"2008","journal-title":"FASEB Journal"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(03)00045-8","article-title":"The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women","volume":"51","author":"Sinclair","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007628.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2011.10630.x","article-title":"Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness","volume":"165","author":"Sinclair","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2006.10.011","article-title":"Characteristic features of Japanese women\u2019s hair with aging and with progressing hair loss","volume":"45","author":"Tajima","year":"2007","journal-title":"Journal of Dermatological Science"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"67","DOI":"10.12788\/j.sder.2015.0142","article-title":"Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia","volume":"34","author":"Torres","year":"2015","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/sj.clpt.1996.164","article-title":"Classification scale for male and female androgenetic alopecia","volume":"59","author":"Trancik\u00a0RJ","year":"1996","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD007628.pub4-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2288-6-52","article-title":"A system for rating the stability and strength of medical evidence","volume":"6","author":"Treadwell","year":"2006","journal-title":"BMC Medical Research Methodology"},{"issue":"8-9","key":"10.1002\/14651858.CD007628.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0531-5565(02)00093-1","article-title":"Molecular mechanisms of androgenetic alopecia","volume":"37","author":"Tr\u00fceb","year":"2002","journal-title":"Experimental Gerontology"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0168|cit168","first-page":"284","article-title":"Systematic approach to hair loss in women","volume":"8","author":"Tr\u00fceb","year":"2010","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2133.1991.tb14749.x","article-title":"Psychological characteristics of women with androgenetic alopecia: a controlled study","volume":"125","author":"Donk","year":"1991","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007628.pub4-BIB0170|cit170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010334.pub2","article-title":"Interventions for hirsutism (excluding laser and photoepilation therapy alone)","author":"Zuuren","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007628.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40257-014-0077-5","article-title":"Androgenetic alopecia: an evidence-based treatment update","volume":"15","author":"Varothai","year":"2014","journal-title":"American Journal of Clinical Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD007628.pub4-BIB0172|cit172","first-page":"2562","article-title":"Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women","volume":"86","author":"Westberg","year":"2001","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1440-0960.2010.00735.x","article-title":"Treatment of female pattern hair loss with the androgen receptor antagonist flutamide","volume":"52","author":"Yazdabadi","year":"2011","journal-title":"Australasian Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-0960.2011.00745.x","article-title":"Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know","volume":"52","author":"Yip","year":"2011","journal-title":"Australasian Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007628.pub4-BIB0175|cit175","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007628.pub2","article-title":"Interventions for androgenic alopecia in women","author":"Cusmanich","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007628.pub4-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007628.pub3","article-title":"Interventions for female pattern hair loss","author":"Zuuren","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007628.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T08:20:51Z","timestamp":1735201251000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007628.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":176,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007628.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}